Last reviewed · How we verify

NCT05452863: O2matic-Card

O2matic Cardiology Protocol

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing O2matic administered oxygen in Heart Diseases in 60 participants. Completed in 18 March 2024.

Timeline
1 March 2022
Primary endpoint
18 March 2023
18 March 2024

Quick facts

Lead sponsorHvidovre University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 March 2022
Primary completion18 March 2023
Estimated completion18 March 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Hvidovre University Hospital

Who can join

30 and older, any sex, with Heart Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Automatic oxygen supply with the O2matic device has been shown to provided an enhanced oxygen treatment in patients with hypoxemia. O2matic was significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia in patients suffering from chronic obstructive pulmonary disease. This trial investigates the effect of using O2matic in hypoxic patients submitted to the Department of Cardiology.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Automated versus manual oxygen administration for patients admitted with acute cardiovascular disease - a study protocol of a randomised controlled trial.
    Taraldsen IA, Grand J, Lukoschewitz JD, Hansen EF, et al · · 2023 · cited 1× · PMID 36999819
  2. Automated oxygen administration versus manual control in acute cardiovascular care: a randomised controlled trial.
    Taraldsen IA, Grand J, Lukoschewitz JD, Seven E, et al · · 2024 · PMID 39486892 · DOI 10.1136/heartjnl-2024-324488

Verify or expand the search:

Other recruiting trials for Heart Diseases

Currently open trials in the same condition.

Other Hvidovre University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05452863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing